Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 3/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25044088 | 0.89 | SLC6A2 (0.45) | KCNH2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3697519 | 0.80 | HTR2A (0.51) | KCNH2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24770740 | 0.80 | HTR2C (0.46) | SLC6A2SLC6A3HTR2CHTR2AHTR3A | |
| Hydrochloric Acid SCHEMBL2884606 | 0.79 | HTR2A (0.50) | KCNH2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16110833 | 0.78 | HTR2A (0.47) | KCNH2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8433245 | 0.78 | DRD2 (0.49) | KCNH2DRD2DRD3HTR2CHTR2A | |
| SCHEMBL12290554 | 0.78 | SMN1; SMN2 (0.48) | HTR2CHTR2AHTR3A | |
| SCHEMBL4520760 | 0.76 | SLC18A3 (0.48) | KCNH2SLC6A2SLC6A4SLC6A3HTR2C | |
| SCHEMBL10693537 | 0.76 | SMN1; SMN2 (0.47) | — | |
| SCHEMBL17103013 | 0.75 | CYP2D6 (0.53) | KCNH2CYP2D6SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5594024-A | ANTIDEPRESSANTS; TREATMENT OF NARCOLEPSY, SCHIZOPHRENIA, DRUG ABUSE | THE UPJOHN COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5462947-A | Nervous system disorders | THE UPJOHN COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| EP-0641320-A1 | NEW CENTRALLY ACTING SUBSTITUTED PHENYLAZACYCLOALKANES | PHARMACIA & UPJOHN COMPANY (US) | 1995-03-08 | — | — | EP | disclosed |
| WO-1992018475-A2 | SUBSTITUTED PHENYLAZACYCLOALKANES AS CNS AGENTS | THE UPJOHN COMPANY (US) | 1992-10-29 | — | — | WO | disclosed |